New hope for anyone who has ever suffered a stroke

Tocotrienols not only lower cholesterol levels naturally but also keep the blood thin and flowing freely; furthermore, they have shown the ability to actually dissolve dangerous arterial plaque that can lead to a heart attack or stroke. They are also exceptional
antioxidants, protecting cells throughout the body from oxidation that can lead to malignancy or damaged blood vessels.

And now there is exciting research that suggests tocotrienols can help extend the lives of stroke patients by reducing the risk of
a second stroke.

If you or someone close to you has survived a stroke, you know that life afterward can be like living with a time bomb. Unless something is done to reverse the underlying disease process, chances are good that a second, possibly fatal, stroke will follow the first.

But recently the medical community was electrified by a study that led to dramatic improvements in stroke patients. The study used a special tocotrienol preparation distilled from palm oil, called PalmVitee. This ultrapure and high-potency formula is produced in Malaysia expressly for use in scientific research. Because of the very limited supply available, it has never been available to consumers.

arteries (measured by ultrasound) rangedThe 50 subjects in this trial had each suffered a first, mild stroke. At the beginning of the study, the degree of blockage of their from 15 percent to 79 percent. Without making any other changes to their diet or medications, half of the subjects began taking 240 milligrams a day of PalmVitee tocotrienols; the remaining half received placebos. After 12 months, researchers repeated the ultrasound examinations—with startling results. Among those taking placebos, 40 percent showed a progression of the disease, with increased blockage of the arteries. The other 60 percent were stable: no worse but no better. None showed any improvement.

For those taking PalmVitee, it was a much different story. An astonishing 28 percent had improved: Their arteries were actually
less obstructed. Sixty-four percent remained stable, with no further progression. Only 8 percent experienced progression of their disease. As one research analyst remarked, “PalmVitee may not reverse atherosclerosis in every patient, but it is a very good insurance policy (92 percent effective) against its progression and actually reversed the disease for one in four patients. This is very exciting in light of the lack of available medical options.”

How to get PalmVitee
Although the results of this trial were stunning, the findings are consistent withassociprevious research demonstrating the positive
effect of tocotrienols on cardiovascular health. However, the unique attributes of PalmVitee may have been a factor in the exceptional outcome. Other palm-derived products are produced from refined palm oil, from which much of the tocotrienol content has been stripped.

PalmVitee, on the other hand, is made from a tocotrienol-rich derivative of the crude oil called PFAD (palm fatty acid derivative).
The result is an exceptionally pure and potent product that has not been excessively refined and processed. Pending further clinical
trials on stroke patients, we cannot assume that other tocotrienol products will produce identical results.

This article was featured in Health Science Institute.